The Maldives has become the first country in the world to attain triple elimination of mother-to-child transmission of ...

Infections, including influenza, COVID-19, HIV, hepatitis C and herpes zoster, can raise the risk of cardiovascular disease (CVD), and vaccines could help lower that risk, according to a study ...

The grand jury that charged former FBI Director James Comey never saw the version of the indictment that interim U.S.

Merck said the combination achieved suppression of the HIV virus at week 48, similar to Biktarvy in the late-stage study.

The investigational oral therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor, in a single tablet ...

Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...

To put this spike into perspective, the rural city of around 32,000 people has now recorded more HIV cases in two years than ...

The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...

Merck on Wednesday said the Phase 3 study of the once-daily, two-drug single-tablet regimen met the success criterion for its primary efficacy hypothesis, showing non-inferiority to the three-drug ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

Merck (MRK) stock gains as new oral HIV tablet matches Gilead's (GILD) three-drug once-daily HIV pill Biktarvy in a Phase 3 ...